91 results
8-K
EX-99.1
STRO
Sutro Biopharma Inc
13 May 24
Sutro Biopharma Reports First Quarter 2024 Financial Results, Business Highlights and Select Anticipated Milestones
4:30pm
, the Company’s ability to fund development activities and achieve development goals, the Company’s ability to protect intellectual property, the value
424B5
STRO
Sutro Biopharma Inc
2 Apr 24
Prospectus supplement for primary offering
4:58pm
existing cash to achieve our business goals, business strategy, market size for our product candidates, potential future milestone and royalty payments … of our technologies and our proprietary product candidates, the successful achievement of the goals of our collaborations, the advancement of the product
8-K
EX-99.1
STRO
Sutro Biopharma Inc
2 Apr 24
Ipsen and Sutro Biopharma announce exclusive global licensing agreement for an ADC targeting solid tumors
6:04am
and results of preclinical and clinical trials, the
Company’s ability to fund development activities and achieve development goals, the Company’s
8-K
ldap52l 2na
2 Apr 24
Ipsen and Sutro Biopharma announce exclusive global licensing agreement for an ADC targeting solid tumors
6:04am
8-K
EX-99.1
4vfsf71k
25 Mar 24
Sutro Biopharma Reports Full Year 2023 Financial Results, Business Highlights and Select Anticipated Milestones
4:30pm
424B5
gh8dl6mex06
9 Feb 24
Prospectus supplement for primary offering
4:25pm
8-K
njpbl
8 Jan 24
Results of Operations and Financial Condition
7:31am
8-K
EX-99.1
6rzdmxntrj0oo8houcr
21 Nov 23
Departure of Directors or Certain Officers
4:05pm
8-K
EX-99.1
kmvsf2
13 Nov 23
Sutro Biopharma Reports Third Quarter 2023 Financial Results, Business Highlights and Select Anticipated Milestones
4:30pm
8-K
EX-99.1
iqcksrdoqn07zt1
10 Aug 23
Sutro Biopharma Reports Second Quarter 2023 Financial Results, Business Highlights and Select Anticipated Milestones
4:31pm